Items where authors include "Johnson, T.S."

Article

Tam, A.Y.Y. orcid.org/0000-0003-0244-0109, Khan, K. orcid.org/0000-0002-5971-314X, Xu, S. orcid.org/0000-0002-3624-2410 et al. (10 more authors) (2025) Critical role for transglutaminase 2 in scleroderma skin fibrosis and in the development of dermal sclerosis in a mouse model of scleroderma. Arthritis & Rheumatology, 77 (7). pp. 914-928. ISSN 2326-5191

Barnouin, K., Tonoli, E., Coveney, C. et al. (9 more authors) (2025) Identification of mechanistic CKD biomarkers in a rat SNx kidney fibrosis model by transcriptomics and proteomics detectable in biofluids. Scientific Reports, 15 (1). 11200. ISSN 2045-2322

Huang, L., Bon, H., Maamra, M. et al. (11 more authors) (2024) The effect of TG2-inhibitory monoclonal antibody zampilimab on tissue fibrosis in human in vitro and primate in vivo models of chronic kidney disease. PLOS ONE, 19 (5). e0298864. ISSN 1932-6203

Da Silva Lodge, M., Pullen, N., Pereira, M. et al. (1 more author) (2022) Urinary levels of pro-fibrotic transglutaminase 2 (TG2) may help predict progression of chronic kidney disease. PLoS ONE, 17 (1). e0262104. ISSN 1932-6203

Huang, L., Ni, J., Duncan, T. et al. (2 more authors) (2021) Development of a unilateral ureteral obstruction model in cynomolgus monkeys. Animal Models and Experimental Medicine, 4 (4). pp. 359-368. ISSN 2576-2095

Zavvos, V., Buxton, A.T., Evans, C. orcid.org/0000-0003-4356-9216 et al. (8 more authors) (2017) A prospective, proteomics study identified potential biomarkers of encapsulating peritoneal sclerosis in peritoneal effluent. Kidney International, 92 (4). pp. 988-1002. ISSN 0085-2538

Burhan, I., Furini, G., Lortat-Jacob, H. et al. (10 more authors) (2016) Interplay between transglutaminases and heparan sulphate in progressive renal scarring. Scientific Reports, 6. 31343. ISSN 2045-2322